A case report on intraportal injection of autologous bone marrow-derived mononuclear cells and liver transplantation in a patient with cirrhosis-Reference-Cited by-同舟云学术

A case report on intraportal injection of autologous bone marrow-derived mononuclear cells and liver transplantation in a patient with cirrhosis

Published:2021-07-12 Issue:2 Volume:23 Page:88-94
ISSN:2412-6160
Container-title:Russian Journal of Transplantology and Artificial Organs
language:
Short-container-title:RJTAO

Author:

Sheraliev A. R.¹,Polikarpov A. A.¹,Tileubergenov I. I.¹,Moiseenko A. V.¹,Granov D. A.¹

Affiliation:

1. Granov Russian Scientific Center of Radiology and Surgical Technology

Abstract

To date, liver transplantation remains the only effective treatment for patients with cirrhosis. Due to lack of other effective, alternative therapeutic methods, the search and development of new treatment technologies is problem number one. The development of cellular technologies is promising for use in clinical practice. Using this observation as an example, the safety and efficacy of cell therapy technology for prolonged stay on the liver transplant waiting list by a patient with cirrhosis is shown. After intraportal injection of autologous bone marrow-derived mononuclear cells, liver cirrhosis stabilized on the CTP and MELD-Na scales for 22 months of observation, which allowed the patient to wait for an organ and successfully undergo liver transplantation.

Publisher

V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs

Subject

Transplantation,Immunology and Allergy

Reference18 articles.

1. Аlexandrov VN, Каmilovа ТА, Каlyuzhnaya LI, Кriventzov АV, Firsanov DV, Chirsky VS et al. Cell therapy in liver cirrhosis. Bulletin of the Russian Military Medical Academy. 2014; 1 (45): 197–202. (In Russ.).

2. Ivashkin VT, Mayevskaya MV, Pavlov CS, Sivolap YuP, Lunkov VD, Zharkova MS et al. Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientific Liver Society. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017; 27 (6): 20–40. (In Russ.). doi.org/10.22416/1382-4376-2017-27-6-20-40.

3. Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology. 2017; 152 (5): 1090–1099. doi.org/10.1053/j.gastro.2017.01.003.

4. Granov AM, Granov DA, Zherebtsov FK, Gerasimova OA, Borovik VV, Osovskikh VV et al. Liver Transplantation. A Single Center Experience of 100 Cases. Russian Journal of Transplantology and Artificial Organs. 2012; 14 (4): 11–16. (In Russ.).

5. Gautier SV. Liver Transplantation in Russia: 25-year experience and current solutions. Russian Journal of Transplantology and Artificial Organs. 2015; 7 (2): 93–95. (In Russ). doi: 10.15825/1995-1191-2015-2-93-95.